AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.
AEON Biopharma has raised $22.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
AEON Biopharma's investors include Daewoong Pharmaceutical, Daewoong.
AEON Biopharma is headquartered in Newport Beach, United States.
AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.
AEON Biopharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AEON Biopharma — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/aeon-biopharma. Accessed August 14, 2026.
VCBacked. (2025). AEON Biopharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aeon-biopharma
{{cite web |title=AEON Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/aeon-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated